ꢁꢁꢁꢂ
278ꢀ ꢀK.A. Eliazyan et al.: Synthesis of [1,3,4]oxadiazolylthiazole derivatives with plant growth stimulant activity
1
NCH3), 4.30 (q, 2H, J = 7.0 Hz, OCH2CH3), 7.26–7.75 (m, 4H, C6H4); 13C tals; mp 236–238°C (with decomp.); yield 2.87 g (78%); H NMR: δ
NMR (coupled): δ 12.9 (4-CH3); 14.0 (OCH2CH3), 20.8 (CH3C6H4), 32.7 2.60 (s, 3H, 4-CH3), 3.55 (s, 3H, 3-NCH3), 7.50–7.90 (m, 5H, C6H5), 14.50
3
(3-NCH3), 61.2 (OCH2CH3), 106.0 (C-5; J = 4.2 Hz), 125.9; 129.4, 138.7; (brs, 1H, NH); 13C NMR (coupled): δ 13.2 (4-CH3), 32.8 (3-NCH3), 99.0
146.6, (Ar); 142.8 (C-4; 2J = 6.6 Hz), 160.4 (С=О, 3J = 3.2 Hz), 165.2 (С-2, (q, 3J = 4.8 Hz, C-5), 125.8, 128.4, 131.8, 140.3 (Ph), 141.5 (q, 2J = 6.6 Hz,
3J = 3.2 Hz). Anal. Calcd for C15H18N2O4S2: C, 50.83; H, 5.12; N, 7.90; S, C-4), 154.5 (C-2′), 164.6 (q, 3J = 3.1 Hz, C-2), 176.4 (C=S). Anal. Calcd for
18.09. Found: C, 50.60; H, 5.06; N, 7.69; S, 17.88.
C13H12N4O3S3: C, 42.38; H, 3.28; N, 15.21; S, 26.11. Found: C, 42.21; H,
3.16; N, 15.00; S, 25.92.
2-(4-Chlorobenzenesulfonylimino)-3,4-dimethyl-5-(5-thi-
oxo-4,5-dihydro-[1,3,4]oxadiazol-2-yl)-2,3-dihydrothiazole
(3b)ꢀYellow crystals; mp 242–244°C (with decomp.); yield 3.30 g
(82%); 1H NMR: δ 2.61 (s, 3H, 4-CH3), 3.53 (s, 3H, 3-NCH3), 7.60–7.92 (m,
4H, C6H4), 14.55 (brs, 1H, NH); 13C NMR (coupled): δ 13.12 (4-CH3), 32.8
General procedure for 2а–c
The suspension of 2-arylsulfonylimino-3,4-dimethylthiazol-5-car-
boxylic acid ethyl ester 1 (0.01 mol) in 15 mL of hydrazine hydrate
(48%) was stirred at 20°С for 2 days. The precipitate was filtered off,
washed with water, and dried. Compounds 2 were purified by boil-
ing in hexane.
3
(3-NCH3), 99.3 (q, J = 4.8 Hz, C-5), 127.6, 128.5, 137.5, 140.1 (Ar), 140.3
(q, 2J = 6.6 Hz, C-4), 154.3 (C-2′), 160.0 (q, 3J = 3.1 Hz, C-2), 176.35 (C=S).
Anal. Calcd for C13H11ClN4O3S3: C, 38.75; H, 2.75; N, 13.91; S, 23.88.
Found: C, 38.62; H, 2.69; N, 13.70; S, 23.61.
2-Benzenesulfonylimino-3,4-dimethyl-2,3-dihydrothiazole-
5-carboxylic acid hydrazideꢀ(2a) White crystals; mp 174–176°C
(with decomp.); yield 2.28 g (70%); 1H NMR: δ 2.45 (s, 3H, 4-CH3), 3.42
(s, 3H, 3-NCH3), 4.50 and 4.84 (brs, 2H, NH2), 7.50–7.87 (m, 5H, C6H5),
8.85 and 9.50 (brs, 1H, NH); 13C NMR: δ 13.0 (4-CH3), 32.7 (3-NCH3),
109.7 (C-5), 125.9, 128.9, 132.3, 140.0 (Ph), 141.7 (C-4), 160.2 (C=O), 164.8
(C-2). Anal. Calcd for C12H14N4O3S2: C, 44.16; H, 4.32; N, 17.17; S, 19.65.
Found: C, 44.02; H, 4.20; N, 16.89; S, 19.44.
2-(4-Methylbenzenesulfonylimino)-3,4-dimethyl-5-(5-thioxo-4,5-
dihydro-[1,3,4]oxadiazol-2-yl)-2,3-dihydrothiazole (3c)ꢀYellow
1
crystals; mp 242–244°C (with decomp.); yield 3.30 g (82%); H NMR:
δ 2.43 (s, 3H, PhCH3), 2.60 (s, 3H, 4-CH3), 3.53 (s, 3H, 3-NCH3) , 7. 2 8 –7.78
(m, 4H, C6H4), 14.50 (brs, 1H, NH); 13C NMR (coupled): δ 13.3 (4-CH3),
20.9 (PhCH3), 33.1 (2-NCH3), 98.6 (q, 3J = 4.8 Hz, C-5), 125.9, 129.4, 138.4,
2
3
141.4 (Ar), 142.7 (q, J = 6.6 Hz, C-4), 154.9 (C-2′), 164.6 (q, J = 3.2 Hz,
C-2), 176.4 (C=S). Anal. Calcd for C14H14N4O3S3: C, 43.96; H, 3.69; N,
14.65; S, 25.15. Found: C, 43.82; H, 3.57; N, 14.31; S, 24.85.
2-(4-Chlorobenzenesulfonylimino)-3,4-dimethyl-2,3-dihydro-
thiazole-5-carboxylic acid hydrazideꢀ(2b) White crystals; mp
191–193°C (with decomp.); yield 3.25 g (90%); 1H NMR: δ 2.50 (s, 3H,
4-CH3), 3.43 (s, 3H, 3-NCH3), 4.50 and 4.80 (brs, 2H, NH2), 7.61–7.92 (m,
4H, C6H4), 8.80 and 9.40 (brs, 1H, NH); 13C NMR: δ 13.0 (4-CH3), 32.7
(3-NCH3), 109.7 (C-5), 127.8, 129.3, 137.3, 140.1 (Ar), 141.7 (C-4), 160.2
(C=O), 164.8 (C-2). Anal. Calcd for C12H13ClN4O3S2: C, 39.94; H, 3.63; N,
15.53; S, 17.77. Found: C, 39.85; H, 3.54; N, 15.30; S, 17.52.
General procedure for 4а–с
To a solution of compound 3 (0.01 mol) and KOH (0.01 mol) in 20 mL
of water at 20°C, 1 mL (0.01 mol) of dimethyl sulfate was added por-
tion-wise. The mixture was stirred at 20°С for 24 h, and the resultant
precipitate of compound 3 was filtered off, washed with water, dried,
and crystallized from benzene.
2-(4-Methylbenzenesulfonylimino)-3,4-dimethyl-2,3-dihydro-
thiazole-5-carboxylic acid hydrazide (2c)ꢀWhite crystals; mp
190–192°C (with decomp.); yield 2.70 g (79%); 1H NMR: δ 2.36 (s, 3H,
PhCH3), 2.45 (s, 3H, 4-CH3), 3.41 (s, 3H, 3-NCH3), 4.51 and 4.83 (brs,
2H, NH2), 7.30–7.78 (m, 4H, C6H4), 8.83 and 9.49 (brs, 1H, NH); 13C
NMR (coupled): δ 13.0 (4-CH3), 20.9 (PhCH3), 32.6 (2-NCH3), 109.6 (m,
C-5), 125.9, 129.4, 138.9 (t, 2J =8.3 Hz), 140.0 (m) (Ar), 142.6 (q, 3J = 6.6
2-Benzenesulfonylimino-3,4-dimethyl-5-(5-methylsulfa-
nyl-[1,3,4]oxadiazol-2-yl-)-2,3-dihydro-thiazole (4a)ꢀWhite crys-
tals; mp 180–182°C; yield 2.98 g (78%); 1H NMR: δ 2.62 (s, 3H, 4-CH3),
2.78 (s, 3H, SCH3), 3.57 (s, 3H, 3-NCH3), 7.48–7.90 (m, 5H, C6H5); 13C
NMR: δ 13.1 (4-CH3), 14.1 (SCH3), 32.8 (3-NCH3), 99.3 (C-5), 125.7, 128.2,
131.6, 139.6 (Ph); 141.5 (C-4), 158.9 (C-2′), 163.3 (C-5′), 164.7 (C-2). Anal.
Calcd for C14H14N4O3S3: C, 43.96; H, 3.69; N, 14.65; S, 25.15. Found: C,
43.82; H, 3.60; N, 14.32; S, 24.84.
3
Hz, C-4), 160.3 (brs, C=O), 164.7 (q, J = 3.0 Hz, C-2). Anal. Calcd for
C13H16N4O3S2: C, 45.87; H, 4.74; N, 16.46; S, 18.84. Found: C, 45.69; H,
4.62; N, 16.20; S, 18.61.
2-(4-Chlorobenzenesulfonylimino)-3,4-dimethyl-5-(5-methyl-
General procedure for 3а–с
sulfanyl-[1,3,4]oxadiazol-2-yl-)-2,3-dihydrothiazole (4b)ꢀWhite
1
crystals; mp 158–160°C; yield 3.12 g (75%); H NMR: δ 2.57 (s, 3H,
To a mixture of hydrazide 2 and 1.2 mL (0.02 mol) of carbon disulfide
in 20 mL of ethanol, at boiling, 1.12 g (0.02 mol) of KOH in 10 mL of
ethanol was added dropwise with continuous stirring. Afer 7 h eth-
anol was evaporated, 10 mL of water was added, and the resultant
suspension was acidified with HCl to pH 4. Afer 2–3 h the precipitate
was filtered off, washed with water, and purified by boiling in etha-
nol (50%).
4-CH3), 2.75 (s, 3H, SCH3), 3.50 (s, 3H, 3-NCH3), 7.60–7.92 (m, 4H, C6H4);
13C NMR (coupled): δ 13.3 (4-CH3), 14.3 (SCH3), 33.3 (3-NCH3), 99.3 (q,
2
3J = 4.8 Hz, C-5), 127.8, 129.2, 137.3, 140.2 (Ar), 141.0 (q, J = 6.6 Hz,
C-4), 159.1 (C-2′), 164.0 (C-5′), 165.0 (q, 3J = 3.1 Hz, C-2). Anal. Calcd for
C14H13ClN4O3S3: C, 40.33; H, 3.14; N, 13.44; S, 23.07. Found: C, 40.20; H,
3.05; N, 13.21; S, 22.79.
2-Benzenesulfonylimino-3,4-dimethyl-5-(5-thioxo-4,5-dihy- 2-(4-Methylbenzenesulfonylimino)-3,4-dimethyl-5-(5-methylsul-
dro-[1,3,4]oxadiazol-2-yl)-2,3-dihydrothiazole (3a)ꢀYellow crys- fanyl-[1,3,4]oxadiazol-2-yl-)-2,3-dihydrothiazole (4c)ꢀWhite crys-
Brought to you by | provisional account
Unauthenticated | 128.82.252.58
Download Date | 8/28/13 12:03 PM